OEM Patient Monitoring Vital Sign OEM Module Market

The growing need for wearable patient monitoring devices is crucial for continuous temperature monitoring, glucose monitoring, pulse oximetry, biosensors, and blood pressure monitoring. These are some of the features of wearable patient monitoring devices. Additionally, the Internet of Things connects these features to wearable patient monitoring devices due to the wide range of applications. Moreover, the rapid development of the IoT makes it easy to monitor patient information. For example, in July 2020, Medtronic plc (Ireland) received US Food Drug and Administration and Conformité Européenne (CE) clearances for its LINQ II Insertable Cardiac Monitor (ICM).

LINQ II is a small wireless ICM for patients with abnormal heart rhythms and for those who require long-term monitoring.

Furthermore, technological advancements in patient monitoring devices are expected to accelerate market growth in the future. Amid the rising demand for the latest technology to be used in patient monitoring devices, the OEM companies have started investing a huge amount in their R&D activities in developing advanced modules & components of patient monitoring and vital sign monitoring system. For instance, in July 2021, VoCare, Inc. (US), launched Vital360, an all-in-one, handheld patient health monitoring device. Vital360 is an advanced grade health monitoring tool that combines multiple biometric measurements in a single handheld device.

Such advancements are likely to accelerate the market growth of patient monitoring devices in the future.

The Global OEM Patient Monitoring and Vital Sign OEM Module Market Industry is significantly influenced by the aging population, which is leading to an increased prevalence of chronic diseases. As individuals age, they often require more frequent monitoring of vital signs to manage health conditions effectively. This demographic shift is driving demand for advanced monitoring solutions that can provide continuous and accurate health data. According to projections, the market is expected to grow to 27.9 USD Billion by 2035, highlighting the necessity for innovative patient monitoring technologies tailored to the needs of older adults.

The Global OEM Patient Monitoring and Vital Sign OEM Module Market Industry is poised for substantial growth, with projections indicating a market size of 12.6 USD Billion in 2024 and an anticipated increase to 27.9 USD Billion by 2035. The compound annual growth rate (CAGR) is estimated at 7.47% from 2025 to 2035, reflecting the increasing demand for advanced patient monitoring solutions. This growth trajectory is influenced by various factors, including technological advancements, an aging population, and rising healthcare expenditures. The market's expansion underscores the critical role of OEM modules in enhancing patient care and operational efficiency across healthcare settings.

The Global OEM Patient Monitoring and Vital Sign OEM Module Market Industry is experiencing rapid technological advancements, which enhance the capabilities of monitoring devices. Innovations such as wireless connectivity, cloud computing, and artificial intelligence are becoming increasingly integrated into patient monitoring systems. These advancements facilitate real-time data transmission and analysis, improving patient outcomes and operational efficiency. For instance, the incorporation of AI algorithms allows for predictive analytics, enabling healthcare providers to anticipate patient needs. As a result, the market is projected to reach 12.6 USD Billion in 2024, reflecting the growing demand for sophisticated monitoring solutions.

Increased healthcare expenditure globally is a critical driver for the Global OEM Patient Monitoring and Vital Sign OEM Module Market Industry. Governments and private sectors are investing more in healthcare infrastructure, which includes the acquisition of advanced patient monitoring systems. This trend is particularly evident in developing countries, where healthcare budgets are expanding to improve service delivery. The rise in spending is likely to enhance the adoption of OEM modules that offer integrated monitoring solutions, thereby contributing to a projected CAGR of 7.47% from 2025 to 2035. This growth underscores the importance of investing in modern healthcare technologies.

The Global OEM Patient Monitoring and Vital Sign OEM Module Market Industry is increasingly shaped by a focus on preventive healthcare. Healthcare providers are shifting from reactive to proactive approaches, emphasizing early detection and management of health issues. This paradigm shift is driving the demand for patient monitoring systems that can provide continuous health data, enabling timely interventions. As healthcare systems prioritize preventive measures, the market is likely to expand, supported by innovations in monitoring technology that facilitate real-time health assessments. This trend aligns with the overall growth trajectory of the market, which is expected to reach substantial figures in the coming years.

The integration of telehealth services is emerging as a significant driver in the Global OEM Patient Monitoring and Vital Sign OEM Module Market Industry. Telehealth facilitates remote patient monitoring, allowing healthcare providers to track vital signs and health metrics without the need for in-person visits. This integration not only enhances patient convenience but also optimizes resource allocation within healthcare systems. As telehealth continues to gain traction, the demand for OEM modules that support remote monitoring capabilities is likely to increase. This trend is indicative of a broader shift towards digital health solutions, which are expected to play a crucial role in the market's growth.

By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. North America OEM patient monitoring and vital sign OEM module market accounted for the largest market share in 2021, owing to increasing cases of cardiovascular diseases, high adoption of patient monitoring devices, and well-established healthcare infrastructure. According to the Centers for Disease Control and Prevention (CDC), more than 750,000 hospitalizations occur each year because of atrial fibrillation in the US.

Furthermore, according to the American Heart Association Research Report 2018, heart disease is the leading cause of death in the US, accounting for one in every seven deaths.

Further, the major countries studied are: The US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: OEM PATIENT MONITORING AND VITAL SIGN OEM MODULE MARKET BY REGION 2022 & 2032

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Europe OEM patient monitoring and vital sign OEM module market accounts for the second-largest market share due to increase in funding and initiatives for research & development, an increase in adoption of advanced OEM technologies, the prevalence of neurological diseases, and an increase in the number of new product launch by market players are driving the growth of the market in the region.

Furthermore, the Germany market of OEM patient monitoring and vital sign OEM module held the largest market share in 2021, and the UK market of OEM patient monitoring and vital sign OEM module is the fastest growing market in the Europe region.

The Asia-Pacific OEM patient monitoring and vital sign OEM module market is expected to grow at a significant share from 2024 to 2032 due to the factors such as presence of big OEM modules and component manufacturers, increasing medical tourism in the region. Moreover, China market of OEM patient monitoring and vital sign OEM module held the largest market share in 2021, and the India market of OEM patient monitoring and vital sign OEM module is the fastest growing market in the Asia-Pacific region.

Major market players are spending a lot of money on R&D to increase their product lines, which will help the market of OEM patient monitoring and vital sign OEM module grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the OEM patient monitoring and vital sign OEM module industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

Sentec AG (Switzerland) is a Swiss medical equipment manufacturing company, which expertise in technologies and products for noninvasive patient monitoring. Sentec AG manufactures digital, integrated sensors, which provide noninvasive, continuous ventilation and oxygenation monitoring. Swisstom (Switzerland), a subsidiary of Sentec AG, offers products smaller in size that can fit into the small spaces of monitor anesthesia machine and ventilator. In December 2018, the company acquired Swisstom. This acquired enhanced Sentec's product and service offering.